These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases. Yamazaki S, Shimbo A, Akutsu Y, Takase H, Morio T, Mori M. Pediatr Rheumatol Online J; 2020 Mar 23; 18(1):26. PubMed ID: 32293465 [Abstract] [Full Text] [Related]
6. Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type. Riebschleger MP, Van Mater HA, Cohn LM, Clark SJ. Pediatr Rheumatol Online J; 2014 Mar 23; 12():38. PubMed ID: 25228851 [Abstract] [Full Text] [Related]
8. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study. Saraux A, Benichou J, Guillevin L, Idbrik L, Job-Deslandre C, Sibilia J, Soudant M, Wendling D, Guillemin F. Clin Exp Rheumatol; 2015 Mar 23; 33(5):602-10. PubMed ID: 26315585 [Abstract] [Full Text] [Related]
9. Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of Glucocorticoids. George MD, Baker JF, Wallace B, Chen L, Wu Q, Xie F, Yun H, Curtis JR. Arthritis Care Res (Hoboken); 2021 Nov 23; 73(11):1597-1605. PubMed ID: 32702188 [Abstract] [Full Text] [Related]
10. Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians. Fayad F, Ziade N, Karam GA, Ghaname W, Khamashta M. Clin Exp Rheumatol; 2018 Nov 23; 36(6):1014-1021. PubMed ID: 29846160 [Abstract] [Full Text] [Related]
11. Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative. Omair MA, Omair MA, Halabi H. Int J Rheum Dis; 2017 Sep 23; 20(9):1185-1192. PubMed ID: 26354409 [Abstract] [Full Text] [Related]
13. Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists. Singh JA, Richards JS, Chang E, Joseph A, Ng B. Arthritis Care Res (Hoboken); 2021 Jul 23; 73(7):998-1003. PubMed ID: 33058485 [Abstract] [Full Text] [Related]
16. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, Kimura Y, CARRA Registry Investigators. J Rheumatol; 2012 Sep 23; 39(9):1867-74. PubMed ID: 22859354 [Abstract] [Full Text] [Related]
17. Peri-Arthroscopic Management of Immunosuppressive Medications in Patients with Rheumatic Disease A Survey of Practice Trends Among Rheumatologists and Sports Medicine Orthopedic Surgeons. Vasavada K, Jazrawi LM, Samuels J. Bull Hosp Jt Dis (2013); 2024 Sep 23; 82(3):186-193. PubMed ID: 39150872 [Abstract] [Full Text] [Related]
18. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis. McMahan R, Balfe LM, Greene L. J Manag Care Pharm; 2012 Sep 23; 18(1 Suppl B):1-16. PubMed ID: 22376227 [Abstract] [Full Text] [Related]
20. Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis. Horneff G, Klein A, Ganser G, Sailer-Höck M, Günther A, Foeldvari I, Weller-Heinemann F. Pediatr Rheumatol Online J; 2017 Nov 07; 15(1):78. PubMed ID: 29116003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]